We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$6.69B
AUM Growth
-$75.7M
Cap. Flow
-$285M
Cap. Flow %
-4.26%
Top 10 Hldgs %
37.76%
Holding
142
New
36
Increased
36
Reduced
23
Closed
20

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$214M
2
DG icon
Dollar General
DG
+$212M
3
DIS icon
Walt Disney
DIS
+$212M
4
FIVE icon
Five Below
FIVE
+$147M
5
NKE icon
Nike
NKE
+$143M

Sector Composition

Rank Sector Weight
1 Healthcare 23.95%
2 Technology 23.37%
3 Consumer Discretionary 18.23%
4 Industrials 16.77%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EYPT icon
76
EyePoint Inc
EYPT
$1.11B
$12.4M 0.19%
1,378,332
+197,132
+17% +$1.89M
ASTR
77
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$12.3M 0.18%
+66,667
New +$10.6M
XENE icon
78
Xenon Pharmaceuticals
XENE
$6.24B
$11.1M 0.17%
594,111
+154,047
+35% +$2.84M
FSRX
79
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$10.6M 0.16%
+1,092,600
New +$10.7M
ALUS
80
DELISTED
Alussa Energy Acquisition Corp
ALUS
$9.91M 0.15%
1,000,000
IFRX icon
81
InflaRx
IFRX
$253M
$9.76M 0.15%
3,285,000
TPTX
82
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9.6M 0.14%
+122,994
New +$9.09M
MOLN
83
Molecular Partners
MOLN
$156M
$8.2M 0.12%
+400,000
New +$7.94M
KZR
84
DELISTED
Kezar Life Sciences
KZR
$7.66M 0.11%
140,996
NHIC
85
DELISTED
NewHold Investment Corp. Class A Common Stock
NHIC
$7.53M 0.11%
750,706
+706
+0.1% +$7.05K
CMRX
86
DELISTED
Chimerix, Inc.
CMRX
$6.6M 0.1%
825,241
-90,023
-10% -$749K
INZY
87
DELISTED
Inozyme Pharma
INZY
$6.22M 0.09%
365,172
+23,745
+7% +$413K
VERV
88
DELISTED
Verve Therapeutics
VERV
$6.03M 0.09%
+100,000
New +$4.15M
NEXI
89
DELISTED
NexImmune, Inc. Common Stock
NEXI
$5.97M 0.09%
14,630
-8,541
-37% -$3.93M
FIVE icon
90
Five Below
FIVE
$12.8B
$5.92M 0.09%
30,636
-769,796
-96% -$147M
OTIC
91
DELISTED
Otonomy, Inc.
OTIC
$5.33M 0.08%
2,387,700
+327,500
+16% +$757K
RACB
92
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$5.07M 0.08%
500,000
MIST icon
93
Milestone Pharmaceuticals
MIST
$147M
$4.68M 0.07%
851,291
PRDS
94
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$3.99M 0.06%
400,000
LENZ
95
LENZ Therapeutics
LENZ
$164M
$3.84M 0.06%
+17,857
New +$3.11M
CYT
96
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$3.75M 0.06%
+175,000
New +$3.28M
TBLA icon
97
Taboola.com
TBLA
$1.09B
$3.62M 0.05%
+350,000
New +$3.62M
GLUE icon
98
Monte Rosa Therapeutics
GLUE
$1.33B
$3.4M 0.05%
+150,000
New +$3.06M
BNTC icon
99
Benitec Biopharma
BNTC
$451M
$3.27M 0.05%
+45,235
New +$3.54M
MCW
100
DELISTED
Mister Car Wash
MCW
$3.23M 0.05%
+150,000
New +$3.19M

Similar funds

Suvretta Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Suvretta Capital Management held 142 positions worth $6.69B, down 1.1% from $6.76B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Suvretta Capital Management withdrew a net $285M in Q2 2021, closing 20 positions and reducing 23 holdings. Its most notable exit was McDonald's, an estimated $214M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Suvretta Capital Management opened a new position in Alphabet (Google) Class C worth $269M.

  • Suvretta Capital Management's largest Q2 2021 buy was Alphabet (Google) Class C: 2,143,380 shares worth $269M.
  • Suvretta Capital Management added most to Amazon in Q2 2021, an estimated $88.8M increase.
  • Suvretta Capital Management's biggest Q2 2021 reduction was Five Below, cutting an estimated $147M.
  • Suvretta Capital Management fully exited McDonald's in Q2 2021, selling an estimated $214M.
  • Suvretta Capital Management's ten largest holdings make up 38% of its $6.69B portfolio in Q2 2021.
  • Suvretta Capital Management opened 36 new positions and closed 20 in Q2 2021.
  • Suvretta Capital Management's portfolio value fell 1.1% quarter-over-quarter to $6.69B.

Based on Suvretta Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.